| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Leap Therapeutics Inc (NASDAQ: LPTX)
LPTX Technical Analysis
1.5
| As on 12th Nov 2025 LPTX SHARE Price closed @ 2.05 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.00 & Sell for SHORT-TERM with Stoploss of 2.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LPTXSHARE Price
| Open | 0.60 | Change | Price | % |
| High | 2.54 | 1 Day | 1.61 | 365.91 |
| Low | 0.58 | 1 Week | 1.63 | 388.10 |
| Close | 2.05 | 1 Month | 1.52 | 286.79 |
| Volume | 769091756 | 1 Year | -0.11 | -5.09 |
| 52 Week High 4.61 | 52 Week Low 0.24 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OPEN | 9.37 | 10.50% |
| PLUG | 2.73 | 7.91% |
| NVDA | 193.80 | 0.33% |
| NVVE | 0.16 | 0.00% |
| LMDX | 0.02 | 0.00% |
| AMD | 258.89 | 9.00% |
| SOFI | 32.21 | 4.07% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LPTX Daily Charts |
LPTX Intraday Charts |
Whats New @ Bazaartrend |
LPTX Free Analysis |
|
|
LPTX Important Levels Intraday
| RESISTANCE | 5.83 |
| RESISTANCE | 4.62 |
| RESISTANCE | 3.87 |
| RESISTANCE | 3.12 |
| SUPPORT | 0.98 |
| SUPPORT | 0.23 |
| SUPPORT | -0.52 |
| SUPPORT | -1.73 |
LPTX Forecast November 2025
| 4th UP Forecast | 3.36 |
| 3rd UP Forecast | 2.94 |
| 2nd UP Forecast | 2.68 |
| 1st UP Forecast | 2.42 |
| 1st DOWN Forecast | 1.68 |
| 2nd DOWN Forecast | 1.42 |
| 3rd DOWN Forecast | 1.16 |
| 4th DOWN Forecast | 0.74 |
LPTX Weekly Forecast
| 4th UP Forecast | 2.90 |
| 3rd UP Forecast | 2.63 |
| 2nd UP Forecast | 2.46 |
| 1st UP Forecast | 2.29 |
| 1st DOWN Forecast | 1.81 |
| 2nd DOWN Forecast | 1.64 |
| 3rd DOWN Forecast | 1.47 |
| 4th DOWN Forecast | 1.20 |
LPTX Forecast2025
| 4th UP Forecast | 10.86 |
| 3rd UP Forecast | 8.03 |
| 2nd UP Forecast | 6.29 |
| 1st UP Forecast | 4.54 |
| 1st DOWN Forecast | -0.44 |
| 2nd DOWN Forecast | -2.19 |
| 3rd DOWN Forecast | -3.93 |
| 4th DOWN Forecast | -6.76 |
Leap Therapeutics Inc ( NASDAQ USA Symbol : LPTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LPTX Business Profile
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts. Address: 47 Thorndike Street, Cambridge, MA, United States, 02141
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service